Does EZETIMIBE Cause Hyperbilirubinaemia? 28 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Hyperbilirubinaemia have been filed in association with EZETIMIBE (Ezetimibe). This represents 0.2% of all adverse event reports for EZETIMIBE.
28
Reports of Hyperbilirubinaemia with EZETIMIBE
0.2%
of all EZETIMIBE reports
0
Deaths
27
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From EZETIMIBE?
Of the 28 reports, 27 (96.4%) required hospitalization, and 4 (14.3%) were considered life-threatening.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EZETIMIBE. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does EZETIMIBE Cause?
Myalgia (2,066)
Fatigue (876)
Drug ineffective (812)
Arthralgia (766)
Dyspnoea (766)
Nausea (742)
Dizziness (717)
Diarrhoea (688)
Headache (626)
Malaise (591)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)
Which EZETIMIBE Alternatives Have Lower Hyperbilirubinaemia Risk?
EZETIMIBE vs EZETIMIBE\ROSUVASTATIN
EZETIMIBE vs EZETIMIBE\SIMVASTATIN
EZETIMIBE vs EZOGABINE
EZETIMIBE vs FACTOR XIII CONCENTRATE
EZETIMIBE vs FAM-TRASTUZUMAB DERUXTECAN-NXKI